Skip to content

Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: a randomised controlled trial.

Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: a randomised controlled trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612001042831
Enrollment
754
Registered
2012-09-28
Start date
2012-10-16
Completion date
2014-04-30
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The efficacy of a smoking cessation intervention initiated during a mental health hospital admission and continued post discharge will be assessed via randomised controlled trial. At 12 months post-test, it is hypothesised that participants receiving the intervention will have a 10% points higher 7-day point prevalence abstinence from smoking (20%) as compared to participants that did not (10%), and a 4% points higher prevalence of prolonged abstinence (5%, as compared to 1%).

Interventions

In inpatient setting: - 10-15 minute motivational interview - 3 quit smoking pamphlets tailored to people with mental illness On discharge: NRT discharge pack In the community: - Up to 12 weeks provision of Nicotine Replacement Therapy (NRT), including patches, gum, lozenges, inhalers and oral spray - 16 weeks of telephone support. These will be delivered weekly between weeks 1 and 4, weekly or fortnightly (participant preference) between weeks 5 and 12, and fortnightly between weeks 12 and 16

In inpatient setting: - 10-15 minute motivational interview - 3 quit smoking pamphlets tailored to people with mental illness On discharge: NRT discharge pack In the community: - Up to 12 weeks provision of Nicotine Replacement Therapy (NRT), including patches, gum, lozenges, inhalers and oral spray - 16 weeks of telephone support. These will be delivered weekly between weeks 1 and 4, weekly or fortnightly (participant preference) between weeks 5 and 12, and fortnightly between weeks 12 and 16. - Proactive referral to Quitline - A one page letter to participants general practitioners (GP) and other mental health professionals outlining their clients participation the study.

Sponsors

University of Newcastle
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

- individual admitted to mental health inpatient facility - smokes cigarettes - capacity to give informed consent - can provide contact details to facilitate communication post discharge.

Exclusion criteria

Non-smoker

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 20, 2026